• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services


  • Print
  • Share
  • E-mail

Overview of the Genomics and Targeted Therapy Group

The Genomics and Targeted Therapy Group, in FDA's Office of Clinical Pharmacology, works to advance the application of genomic technologies in the discovery, development, regulation, and use of medications.  

Through pre-market review of therapeutics, policy development, regulatory research, and education, the Group ensures that pharmacogenomic and targeted development strategies are appropriately promoted and proactively applied in all phases of drug development.